首页>
美国卫生研究院文献>EClinicalMedicine
>Efficacy of oral 20-hydroxyecdysone (BIO101) a MAS receptor activator in adults with severe COVID-19 (COVA): a randomized placebo-controlled phase 2/3 trial
【2h】
Efficacy of oral 20-hydroxyecdysone (BIO101) a MAS receptor activator in adults with severe COVID-19 (COVA): a randomized placebo-controlled phase 2/3 trial
展开▼
机译:口服 20-羟基蜕皮激素 (BIO101)一种 MAS 受体激活剂对成人重症 COVID-19 (COVA) 的疗效:一项随机、安慰剂对照、2/3 期试验